menu
    • menu

    Company profile for Nuevocor

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nuevocor’s LMNA gene therapy is based on decades of research into fundamental mechanisms underlying LMNA-associated disease enabled by the development of novel technologies on the part of scientific co-founders Colin Stewart and Brian Burke. Together with the AAV gene therapy and cardiac disease modeling expertise of scientific co-founders Mark Kay and Jianming Jiang respectively, Nuevocor is well-positioned to cure LMNA a...
    Nuevocor’s LMNA gene therapy is based on decades of research into fundamental mechanisms underlying LMNA-associated disease enabled by the development of novel technologies on the part of scientific co-founders Colin Stewart and Brian Burke. Together with the AAV gene therapy and cardiac disease modeling expertise of scientific co-founders Mark Kay and Jianming Jiang respectively, Nuevocor is well-positioned to cure LMNA and other genetic cardiomyopathies, amongst other cardiac diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NuevocorSingapore Flag
    Country
    Country
    Singapore
    Address
    Address
    3 Biopolis Drive, Synapse #06-11/12/13 Singapore 138623
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nuevocor.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nuevocor/?originalSubdomain=sg
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nuevocor Appoints Al Gianchetti As Chief Executive Officer
    Nuevocor Appoints Al Gianchetti As Chief Executive Officer

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/nuevocor-appoints-al-gianchetti-as-chief-executive-officer

    PHARMIWEB
    07 Jan 2026
    Share Share
    Nuevocor Strengthens Board with Appointment of Thierry Abribat
    Nuevocor Strengthens Board with Appointment of Thierry Abribat

    07 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuevocor-strengthens-board-with-appointment-of-thierry-abribat-302498560.html

    PR NEWSWIRE
    07 Jul 2025
    Share Share
    Nuevocor Raises $45M For Genetic Cardiomyopathy Therapy
    Nuevocor Raises $45M For Genetic Cardiomyopathy Therapy

    06 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/06/3074699/0/en/Angelini-Ventures-Co-Leads-45-Million-Series-B-Financing-of-Nuevocor-to-Advance-Transformative-Treatment-for-Genetic-Dilated-Cardiomyopathy.html

    GLOBENEWSWIRE
    06 May 2025
    Share Share
    Nuevocor Welcomes Andreas as Chairman of Board of Directors
    Nuevocor Welcomes Andreas as Chairman of Board of Directors

    24 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuevocor-welcomes-andreas-wallnofer-as-chairman-of-the-board-of-directors-302359634.html

    PR NEWSWIRE
    24 Jan 2025
    Share Share
    Nuevocor Appoints John Lee As Chief Medical Officer
    Nuevocor Appoints John Lee As Chief Medical Officer

    11 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuevocor-strengthens-leadership-team-with-appointment-of-john-lee-as-chief-medical-officer-302114117.html

    PR NEWSWIRE
    11 Apr 2024
    Share Share
    Nuevocor to Present at Biotech Showcase during JPM week
    Nuevocor to Present at Biotech Showcase during JPM week

    21 Dec 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/nuevocor-to-present-at-biotech-showcase-during-jpm-week-and-at-keystone-symposium-on-heart-development-and-disease-301707333.html

    PRNEWSWIRE
    21 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search